SCHEMBL18734942

SCHEMBL18734942

CCOC(=O)C(=O)CC(=O)SCC(NC(=O)C(C)CC)C(=O)N(CC)CC

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 1/20 0.30
▸ METAP1 P53582 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18734931 0.91 — —
SCHEMBL18734927 0.88 ALOX15 (0.32) —
SCHEMBL18735173 0.88 MGAM (0.33) —
SCHEMBL18735314 0.87 METAP2 (0.35) METAP2METAP1
SCHEMBL18734935 0.84 KMT2A (0.32) —
SCHEMBL18735152 0.83 — —
SCHEMBL18734956 0.81 MGAM (0.32) METAP2METAP1
SCHEMBL18735171 0.81 ALOX15 (0.33) —
SCHEMBL18734939 0.81 — —
SCHEMBL18735313 0.81 METAP2 (0.34) METAP2METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017060400-A1 PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS NEUROVIVE PHARMACEUTICAL AB (SE) 2017-04-13 — — WO disclosed
Send feedback